Silver Sulfadiazine Articles
Solvay viewing options for pharma
2 April 2009
York Pharma buys brands from Solvay
13 October 2008
Harvard Health warns against colloidal silver
6 August 2007
HMR sells brands to King Pharma
24 December 1998
Showing 1-6 of 6 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
